Dacomitinib Intermediate 2 NEW

$35.00 10mg

$56.00 25mg

$82.00 50mg

Min. Order
Purity99.27%
Cas No179552-74-0
Supply Ability10g
Update time2025-11-10

TargetMol Chemicals Inc.

VIP6Y

United States

Since:2011-01-07

Address:36 Washington Street, Wellesley Hill, MA

show less show more

Enterprise Verified

Business Bank account Basic Contact Infomation Business Address Trade Company

Chemical Properties

Product Name	Dacomitinib Intermediate 2
CAS No	179552-74-0
EC-No
Min. Order
Purity	99.27%
Supply Ability	10g
Release date	2025/11/10

Product Introduction

Bioactivity

Name	Dacomitinib Intermediate 2
Description	Dacomitinib Intermediate 2 (N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine) has anticancer activity and can be used to study lung cancer.
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice/Shipping at ambient temperature.
Solubility Information	DMSO : 16.67 mg/mL (47.79 mM), Sonication is recommended.
Related Compound Libraries	Anti-Lung Cancer Compound Library \| Bioactive Compound Library \| Bioactive Compounds Library Max \| Anti-Cancer Compound Library \| Anti-Cancer Active Compound Library

show less show more

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.